[144] Procter & Gamble Company SEC Filing
Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $156,460. The filer reports acquiring 15,811 shares as a Performance Stock Program Award from Procter & Gamble and intends the sale approximately on 08/29/2025. The filing also discloses that the filer sold 6,167 shares for gross proceeds of $969,907.53. The notice includes the signed representation that the seller is unaware of undisclosed material adverse information about the issuer.
Avviso Form 144 per Procter & Gamble Company (PG) indica una proposta di vendita di 1.000 azioni di capitale sociale tramite Morgan Stanley Smith Barney, con un valore di mercato complessivo di $156.460. Il dichiarante riporta di aver acquisito 15.811 azioni in data 08/18/2025 come Performance Stock Program Award da Procter & Gamble e intende effettuare la vendita approssimativamente il 08/29/2025. La comunicazione segnala inoltre che il dichiarante ha venduto 6.167 azioni il 08/19/2025 per proventi lordi di $969.907,53. L鈥檃vviso include la dichiarazione firmata che il venditore non 猫 a conoscenza di informazioni materiali negative non divulgate sull鈥檈mittente.
Aviso Form 144 para Procter & Gamble Company (PG) muestra una propuesta de venta de 1.000 acciones de capital com煤n a trav茅s de Morgan Stanley Smith Barney, con un valor de mercado agregado de $156,460. El declarante informa haber adquirido 15.811 acciones el 08/18/2025 como Performance Stock Program Award de Procter & Gamble y tiene previsto vender aproximadamente el 08/29/2025. La presentaci贸n tambi茅n revela que el declarante vendi贸 6.167 acciones el 08/19/2025 por ingresos brutos de $969.907,53. El aviso incluye la declaraci贸n firmada de que el vendedor desconoce la existencia de informaci贸n material adversa no divulgada sobre el emisor.
Procter & Gamble Company (PG) 甏�霠� Form 144 瓿奠鞐� 霐半ゴ氅� Morgan Stanley Smith Barney毳� 韱淀暣 氤错喌欤� 1,000欤� 毵る弰毳� 鞝滌晥頄堨溂氅� 齑� 鞁滉皜 臧�旃橂姅 $156,460鞛呺媹雼�. 鞝滌稖鞛愲姅 Procter & Gamble搿滊秬韯� 15,811欤�毳� 08/18/2025鞐� Performance Stock Program Award搿� 旆摑頄堨溂氅� 毵る弰 鞓堨爼鞚检潃 雽�霝� 08/29/2025霛缄碃 氤搓碃頄堨姷雼堧嫟. 霕愴暅 鞝滌稖靹滌棎電� 鞝滌稖鞛愱皜 08/19/2025鞐� 6,167欤�毳� 毵る弰頃橃棳 齑濎垬鞛� $969,907.53毳� 鞏混棃雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓿奠鞐愲姅 韺愲Г鞛愱皜 氚滍枆鞚胳棎 甏�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岇 氇豁暅雼る姅 靹滊獏霅� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avis Form 144 pour Procter & Gamble Company (PG) indique une proposition de vente de 1 000 actions ordinaires via Morgan Stanley Smith Barney, pour une valeur marchande totale de 156 460 $. Le d茅clarant signale avoir acquis 15 811 actions le 08/18/2025 en tant que Performance Stock Program Award de Procter & Gamble et pr茅voit la vente aux alentours du 08/29/2025. Le d茅p么t r茅v猫le 茅galement que le d茅clarant a vendu 6 167 actions le 08/19/2025 pour un produit brut de 969 907,53 $. L鈥檃vis comprend la d茅claration sign茅e selon laquelle le vendeur n鈥檈st pas au courant d鈥檌nformations d茅favorables importantes non divulgu茅es concernant l鈥櫭﹎etteur.
Form-144-Mitteilung f眉r Procter & Gamble Company (PG) zeigt einen vorgeschlagenen Verkauf von 1.000 Aktien des Stammkapitals 眉ber Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $156.460. Der Einreicher berichtet, 15.811 Aktien am 08/18/2025 als Performance Stock Program Award von Procter & Gamble erworben zu haben und beabsichtigt den Verkauf ungef盲hr am 08/29/2025. Die Einreichung legt au脽erdem offen, dass der Einreicher am 08/19/2025 6.167 Aktien verkauft hat und damit Bruttoeinnahmen von $969.907,53 erzielte. Die Mitteilung enth盲lt die unterzeichnete Erkl盲rung, dass der Verk盲ufer 眉ber keine nicht offengelegten, ma脽geblichen negativen Informationen 眉ber den Emittenten Kenntnis hat.
- None.
- None.
Insights
TL;DR: Routine insider sale notice; transaction sizes are small relative to issuer's outstanding shares.
The Form 144 documents a proposed sale of 1,000 shares valued at $156,460 and recent sales of 6,167 shares for $969,907.53. With total shares outstanding stated as 2,342,371,488, these transactions represent a de minimis fraction of the company equity and do not, by themselves, imply material change to ownership or control. The acquisition date and nature (performance stock award) are disclosed, which is typical for equity compensation-driven sales. Impact on market or governance is likely negligible based on disclosed sizes.
TL;DR: Filing meets Rule 144 procedural requirements; includes standard certification about material nonpublic information.
The notice contains required elements: broker identity, share amounts, acquisition method (performance award), dates of acquisition and intended sale, and prior sales within three months. The signer affirms no undisclosed material adverse information and references trading-plan considerations consistent with Rule 10b5-1 language. From a governance perspective, disclosures are complete as presented; there is no indication of unusual timing or size that would raise compliance concerns based on the disclosed facts alone.
Avviso Form 144 per Procter & Gamble Company (PG) indica una proposta di vendita di 1.000 azioni di capitale sociale tramite Morgan Stanley Smith Barney, con un valore di mercato complessivo di $156.460. Il dichiarante riporta di aver acquisito 15.811 azioni in data 08/18/2025 come Performance Stock Program Award da Procter & Gamble e intende effettuare la vendita approssimativamente il 08/29/2025. La comunicazione segnala inoltre che il dichiarante ha venduto 6.167 azioni il 08/19/2025 per proventi lordi di $969.907,53. L鈥檃vviso include la dichiarazione firmata che il venditore non 猫 a conoscenza di informazioni materiali negative non divulgate sull鈥檈mittente.
Aviso Form 144 para Procter & Gamble Company (PG) muestra una propuesta de venta de 1.000 acciones de capital com煤n a trav茅s de Morgan Stanley Smith Barney, con un valor de mercado agregado de $156,460. El declarante informa haber adquirido 15.811 acciones el 08/18/2025 como Performance Stock Program Award de Procter & Gamble y tiene previsto vender aproximadamente el 08/29/2025. La presentaci贸n tambi茅n revela que el declarante vendi贸 6.167 acciones el 08/19/2025 por ingresos brutos de $969.907,53. El aviso incluye la declaraci贸n firmada de que el vendedor desconoce la existencia de informaci贸n material adversa no divulgada sobre el emisor.
Procter & Gamble Company (PG) 甏�霠� Form 144 瓿奠鞐� 霐半ゴ氅� Morgan Stanley Smith Barney毳� 韱淀暣 氤错喌欤� 1,000欤� 毵る弰毳� 鞝滌晥頄堨溂氅� 齑� 鞁滉皜 臧�旃橂姅 $156,460鞛呺媹雼�. 鞝滌稖鞛愲姅 Procter & Gamble搿滊秬韯� 15,811欤�毳� 08/18/2025鞐� Performance Stock Program Award搿� 旆摑頄堨溂氅� 毵る弰 鞓堨爼鞚检潃 雽�霝� 08/29/2025霛缄碃 氤搓碃頄堨姷雼堧嫟. 霕愴暅 鞝滌稖靹滌棎電� 鞝滌稖鞛愱皜 08/19/2025鞐� 6,167欤�毳� 毵る弰頃橃棳 齑濎垬鞛� $969,907.53毳� 鞏混棃雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓿奠鞐愲姅 韺愲Г鞛愱皜 氚滍枆鞚胳棎 甏�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岇 氇豁暅雼る姅 靹滊獏霅� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avis Form 144 pour Procter & Gamble Company (PG) indique une proposition de vente de 1 000 actions ordinaires via Morgan Stanley Smith Barney, pour une valeur marchande totale de 156 460 $. Le d茅clarant signale avoir acquis 15 811 actions le 08/18/2025 en tant que Performance Stock Program Award de Procter & Gamble et pr茅voit la vente aux alentours du 08/29/2025. Le d茅p么t r茅v猫le 茅galement que le d茅clarant a vendu 6 167 actions le 08/19/2025 pour un produit brut de 969 907,53 $. L鈥檃vis comprend la d茅claration sign茅e selon laquelle le vendeur n鈥檈st pas au courant d鈥檌nformations d茅favorables importantes non divulgu茅es concernant l鈥櫭﹎etteur.
Form-144-Mitteilung f眉r Procter & Gamble Company (PG) zeigt einen vorgeschlagenen Verkauf von 1.000 Aktien des Stammkapitals 眉ber Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $156.460. Der Einreicher berichtet, 15.811 Aktien am 08/18/2025 als Performance Stock Program Award von Procter & Gamble erworben zu haben und beabsichtigt den Verkauf ungef盲hr am 08/29/2025. Die Einreichung legt au脽erdem offen, dass der Einreicher am 08/19/2025 6.167 Aktien verkauft hat und damit Bruttoeinnahmen von $969.907,53 erzielte. Die Mitteilung enth盲lt die unterzeichnete Erkl盲rung, dass der Verk盲ufer 眉ber keine nicht offengelegten, ma脽geblichen negativen Informationen 眉ber den Emittenten Kenntnis hat.
FAQ
What does Procter & Gamble's (PG) Form 144 filed here report?
Who acquired the shares being sold and how were they acquired?
Has the filer sold any PG shares recently?
Which broker is handling the proposed sale?
Does the filing state the number of shares outstanding for PG?
